145 related articles for article (PubMed ID: 2434029)
1. [Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
Yoshimoto J; Ochi J; Tanahashi T; Nanba K; Saegusa M; Hara M; Akagi T; Obama T; Tsushima T; Ozaki Y
Gan To Kagaku Ryoho; 1987 Feb; 14(2):434-9. PubMed ID: 2434029
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of hormonal refractory adenocarcinoma of the prostate with ifosfamide (IFM) and the combination of vincristine ifosfamide and peplomycin (VIP)].
Nukui M; Nakao M; Nakagawa S; Toyoda K; Takada H; Ebisui K; Watanabe H; Miyakoda K; Kobayashi T; Fujiwara M
Hinyokika Kiyo; 1989 Mar; 35(3):415-20. PubMed ID: 2472052
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy with ifosfamide (or cyclophosphamide), adriamycin, cis-platinum and peplomycin (IAPP) for hormonally resistant metastatic prostatic cancer].
Maeda O; Saiki S; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
Hinyokika Kiyo; 1991 Dec; 37(12):1657-62. PubMed ID: 1723841
[TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with reactivated prostatic cancer].
Kazama T; Katayama T; Umeda K; Akiya T; Nakada T
Hinyokika Kiyo; 1986 Feb; 32(2):201-5. PubMed ID: 2425607
[TBL] [Abstract][Full Text] [Related]
5. [Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer].
Takeuchi S; Fukui I; Higashi Y; Andoh M; Kihara K; Kitahara S; Horiuchi S; Oshima H
Hinyokika Kiyo; 1989 Sep; 35(9):1513-7. PubMed ID: 2816618
[TBL] [Abstract][Full Text] [Related]
6. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: a preliminary report.
Logothetis CJ; von Eschenbach AC; Samuels ML; Trindade A; Johnson DE
Cancer Treat Rep; 1982 Jan; 66(1):57-63. PubMed ID: 7053267
[TBL] [Abstract][Full Text] [Related]
8. [Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
Ushiyama T; Ihara H; Kurita Y; Kageyama S; Ueda D; Mugiya S; Yamaguchi Y; Nakano M; Suzuki K; Kawabe K
Hinyokika Kiyo; 1993 Dec; 39(12):1139-44. PubMed ID: 8285162
[TBL] [Abstract][Full Text] [Related]
9. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy with peplomycin, cis-platinum and mitomycin C in gynecologic cancer].
Yasui Y; Suzumori K; Asai H; Yagami Y
Gan No Rinsho; 1985 Sep; 31(11):1415-21. PubMed ID: 2415720
[TBL] [Abstract][Full Text] [Related]
11. [Alternative combination chemotherapy with mitomycin C, vincristine, methotrexate, 5-fluorouracil, cis-platinum and adriamycin for adenocarcinoma of the lung].
Xing FY; Liu WH; Dong W; Zhang SL; Gu BW; Okazaki K; Naito H; Inoue T; Wu JT; Tamura S
Gan To Kagaku Ryoho; 1993 Feb; 20(2):259-63. PubMed ID: 8434964
[TBL] [Abstract][Full Text] [Related]
12. [5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland].
Inoue K; Horikoshi N; Mukaiyama T; Ogawa M; Kuraishi Y
Gan No Rinsho; 1989 Mar; 35(4):481-5. PubMed ID: 2654442
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: clinical effect and renal toxicity].
Fujii M; Kiura K; Okabe K; Toki H
Gan To Kagaku Ryoho; 1987 Jan; 14(1):105-8. PubMed ID: 3099647
[TBL] [Abstract][Full Text] [Related]
14. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
Konami T; Wakabayashi Y; Kim T; Ishida A; Arai Y; Konishi T; Pak K; Takeuchi H; Tomoyoshi T; Watanabe J
Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy of diffuse large-cell non-Hodgkin's lymphoma--superiority of the adriamycin combination].
Tada A; Ohnoshi T; Hayashi K; Ueoka H; Ueno K; Murashima M; Mizuta J; Yoshida M; Kimura I
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2692-6. PubMed ID: 2443077
[TBL] [Abstract][Full Text] [Related]
16. [Combination chemotherapy consisting of cis-platinum and adriamycin in non-small cell carcinoma of the lung].
Fujii M; Okabe K; Ishikawa M; Toki H; Fujita Y; Araki Y
Gan To Kagaku Ryoho; 1984 Feb; 11(2):265-9. PubMed ID: 6198968
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy for advanced and recurrent cancer patients--the effect of combination chemotherapy using cisplatin, peplomycin, mitomycin C, adriamycin, and 5-fluorouracil].
Sato Y; Tohma H; Shikama T
Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1565-70. PubMed ID: 1700039
[TBL] [Abstract][Full Text] [Related]
18. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
19. Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer.
Amato RJ; Hernandez-McClain J; Henary H
Am J Clin Oncol; 2008 Dec; 31(6):532-8. PubMed ID: 19060583
[TBL] [Abstract][Full Text] [Related]
20. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
Theodors A; Bukowski RM; Hewlett JS; Livingston RB; Weick JK
Am J Clin Oncol; 1982 Oct; 5(5):555-8. PubMed ID: 6217742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]